DURAFIBER Ag was designed to be an absorbent, non-woven, silver containing antimicrobial dressing composed of cellulose ethyl sulponate fibres. The ionic silver in the dressing provides antimicrobial activity against a broad spectrum of common wound pathogens which help to reduce bacterial bioburden and the risk of infection. This dressing rapidly forms a clear, cool gel on contact with wound fluid. The gel absorbs excess fluid and locks exudate away from the wound. DURAFIBER Ag provides a moist environment to support autolytic debridement and conforms intimately to the wound bed. Can be used in conjunction with a range of cover dressings including ALLEVYN and PROFORE. DURAFIBER Ag may also be used with OPSITE on lightly exuding wounds.
DURAFIBER Ag Features:
- Provides antimicrobial activity against a broad spectrum of common wound pathogens.
- Produces rapidly formed, clear, cool gel when in contact with wound fluid.
- Easy, one-piece removal from moist wound beds and cavity wounds.
- Minimizes trauma to the wound and pain to the patient.
- Highly absorbent.
- Size: 0.75" x 17.75"
- MPN: 66800574
- Contains 6 Packs of 5 DURAFIBER Ag Gelling Fiber Dressing, 0.75" x 17.75".
DURAFIBER Ag Uses:
DURAFIBER Ag should be used as an absorbent, antimicrobial gelling dressing for the management of chronic and acute, full thickness, partial thickness, or shallow granulating exuding wounds. For example: leg ulcers, pressure ulcers, diabetic ulcers, surgical wounds, traumatic wounds, donor sites, partial thickness burns, tunneling and fistulae wounds, wounds left to heal by secondary intent, and wounds that are prone to bleeding such as wounds that have been surgically or mechanically debrided. Can be left in place for up to 7 days and may be used on infected wounds. Where the product is used on infected wounds the infection should be inspected and treated as per local protocol.
- Clinicians/Healthcare Professionals should be aware that there are very limited data on prolonged and repeated use of silver containing dressings, particularly in children and neonates.
- Whilst DURAFIBER Ag assists in the management of wounds prone to minor bleeding, it is not intended to be used as a surgical sponge in heavily bleeding wounds.
- This dressing is not compatible with oil-based products such as petrolatum.
- Avoid contact with electrodes or conductive gels during electronic measurements such as EEG and ECG.
- Ensure that packing in cavities sinuses etc has been removed.
- The dressing may not be compatible with topical antimicrobials. If reddening or sensitisation occurs, discontinue use. In the event of clinical infection, topical silver does not replace the need for systemic therapy or other adequate infection treatment.
- When DURAFIBER Ag is used on a patient during an MRI examination, some warming may be experienced.
- May cause transient discoloration of the surrounding skin.
- Cleanse the wound according to local clinical protocol.
- Select appropriate dressing size.
- Remove the DURAFIBER Ag dressing from pack using a clean technique. Cut to shape if necessary.
- Apply the dressing to the wound and allow for a 1 cm / 1/2in dressing overlap onto the skin surrounding the wound.
- When using DURAFIBER Ag in deep cavity wounds, use whole dressing where possible and leave at least 2.5cm / 1in. of each piece outside the wound for easy retrieval.
- Loosely pack deep wounds up to 80% capacity as DURAFIBER Ag will expand on contact with wound fluid.
- Secure DURAFIBER Ag with a moisture retentive dressing like ALLEVYN/OPSITE or other appropriate secondary retention.
- The dressing can be removed in one piece using sterile tweezers, forceps or a gloved hand.
- The dressing may adhere if used on lightly exuding wounds. If the dressing is not easily removed, moisten or soak the dressing in a sterile saline to assist in the removal and avoid disruption of the healing wound.
Frequency of Change
During the early stages of wound management, DURAFIBER dressings should be inspected frequently. Dressings can be left undisturbed for up to 7 days or changed when clinically indicated. For example if leakage or excessive bleeding is present. Local clinical protocol should also be taken into consideration. DURAFIBER Ag is a single use product. If used on more than one patient, cross-contamination or infection may result. Opening the dressing pack compromises the sterile barrier. Any unused dressing should be discarded.